|
Cogaine moves to phase 2
Phytopharm moves forward on Cogane Phase II trial
Business Financial Newswire - Pharmaceutical development and food development company Phytopharm said progress was being made towards a Phase II clinical trial of Cogane, its Parkinson's disease treatment, following US regulatory approval. Patient enrolment was planned to begin in late 2010 and results expected in late 2012. http://www.bfnnews.com/display/?id=3...d=standardNews |
| All times are GMT -5. The time now is 09:36 PM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.